NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

etoro logo Buy XERS
*Your capital is at risk
$5.89
-0.110 (-1.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 1, 2025 $8.02 -1.50% $8.01 V 99.90% 6
Oct 1, 2025 $8.06 -0.94% $8.01 V 99.33% 4
Oct 1, 2025 $8.40 +3.96% $8.01 X 95.13% 0
Sep 30, 2025 $7.95 -1.55% $8.14 X 97.73% 0
Sep 30, 2025 $8.00 -0.97% $8.14 X 98.30% 0
Sep 29, 2025 $8.05 -1.54% $8.08 V 99.67% 5
Sep 29, 2025 $8.10 -0.97% $8.08 V 99.74% 5
Sep 29, 2025 Bullish $8.08 X 0
Aug 25, 2025 $7.75 +0.00% $7.77 X 99.74% 4
Aug 14, 2025 $7.16 -1.63% $7.30 X 98.10% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE